1. Home
  2. VSH vs TVTX Comparison

VSH vs TVTX Comparison

Compare VSH & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • TVTX
  • Stock Information
  • Founded
  • VSH 1962
  • TVTX 2008
  • Country
  • VSH United States
  • TVTX United States
  • Employees
  • VSH N/A
  • TVTX N/A
  • Industry
  • VSH Electrical Products
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSH Technology
  • TVTX Health Care
  • Exchange
  • VSH Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • VSH 2.3B
  • TVTX 2.5B
  • IPO Year
  • VSH N/A
  • TVTX N/A
  • Fundamental
  • Price
  • VSH $16.72
  • TVTX $34.48
  • Analyst Decision
  • VSH Hold
  • TVTX Strong Buy
  • Analyst Count
  • VSH 1
  • TVTX 16
  • Target Price
  • VSH $19.00
  • TVTX $35.20
  • AVG Volume (30 Days)
  • VSH 1.7M
  • TVTX 2.0M
  • Earning Date
  • VSH 11-05-2025
  • TVTX 10-30-2025
  • Dividend Yield
  • VSH 2.38%
  • TVTX N/A
  • EPS Growth
  • VSH N/A
  • TVTX N/A
  • EPS
  • VSH N/A
  • TVTX N/A
  • Revenue
  • VSH $2,927,555,000.00
  • TVTX $435,826,000.00
  • Revenue This Year
  • VSH $4.58
  • TVTX $83.23
  • Revenue Next Year
  • VSH $7.19
  • TVTX $41.49
  • P/E Ratio
  • VSH N/A
  • TVTX N/A
  • Revenue Growth
  • VSH N/A
  • TVTX 114.22
  • 52 Week Low
  • VSH $10.35
  • TVTX $12.91
  • 52 Week High
  • VSH $20.15
  • TVTX $35.86
  • Technical
  • Relative Strength Index (RSI)
  • VSH 52.31
  • TVTX 80.46
  • Support Level
  • VSH $16.64
  • TVTX $26.79
  • Resistance Level
  • VSH $17.79
  • TVTX $30.97
  • Average True Range (ATR)
  • VSH 0.63
  • TVTX 1.30
  • MACD
  • VSH -0.03
  • TVTX 0.50
  • Stochastic Oscillator
  • VSH 38.57
  • TVTX 85.85

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: